Idorsia Ltd is a Switzerland-based biopharmaceutical company, which specializes in the discovery and development of small molecules, to meet significant unmet medical needs. The Company will have a diverse clinical development pipeline comprising several compounds being investigated in multiple therapeutic areas, including central nervous system disorders, cardiovascular disorders, immunological disorders and orphan diseases. The Company's development compounds target a number of different diseases such as: Resistant Hypertension, Systemic lupus erythematosus, Chronic insomnia and Fabry disease, among others.

Pharmaceutical

Idorsia

Idorsia's headquarters in Allschwil, Switzerland

Jean-Paul Clozel

André C. Muller

Martine Clozel

Joseph Bejjani

Antonio Olivieri

Benjamin Limal

Dominique L.

Manuel Ortega

Arno Groenewoud

Julien Gander

Peter Kellogg

Felix R. Ehrat

Srishti Gupta

Sophie Kornowski

Sandy Mahatme

Mathieu Simon

The Leadership Team at Idorsia directs the strategic vision and operational execution of the company's biopharmaceutical development initiatives. Comprising top executives from diverse functional areas, including drug discovery, clinical development, finance, regulatory affairs, and human resources, this team collaborates to drive innovation and ensure the successful advancement of the company's clinical pipeline, ultimately aiming to address unmet medical needs across various therapeutic areas. Their collective expertise enables decision-making that aligns with Idorsia's mission to pioneer groundbreaking treatments and enhance patient outcomes.

Leadership Team

The Clinical Operations Team at Idorsia is responsible for the strategic planning, execution, and oversight of clinical trials across the company's diverse therapeutic pipeline. This team ensures compliance with regulatory standards, manages trial logistics, and coordinates cross-functional collaboration to facilitate the timely and efficient advancement of investigational compounds. With a focus on risk-based quality management, the team works to optimize clinical development processes while maintaining the highest safety and quality standards for all clinical research activities.

Clinical Operations Team

The Drug Discovery Team at Idorsia is dedicated to the innovative discovery and development of small molecule therapeutics across various therapeutic areas. This multidisciplinary team collaborates on target identification, lead compound optimization, and preclinical formulation, leveraging expertise in biology, chemistry, and pharmacology to advance promising candidates through the early stages of development. By integrating cutting-edge research with a focus on unmet medical needs, the team aims to bring transformative therapies to patients suffering from complex conditions.

Drug Discovery Team

The Quality Assurance and Compliance Team at Idorsia is responsible for ensuring that all biopharmaceutical processes adhere to regulatory standards and internal quality protocols. This team conducts audits, monitors compliance with Good Manufacturing Practices (GMP), and oversees data integrity across clinical development to facilitate the safe and effective delivery of innovative treatments. Their collaborative efforts help maintain the integrity of Idorsia's diverse clinical pipeline and promote patient safety across various therapeutic areas.

Quality Assurance and Compliance Team

The Marketing Management Team at Idorsia is responsible for developing and executing strategic marketing initiatives to promote the company’s diverse portfolio of therapeutic compounds. This team collaborates across regions and functions to ensure effective market access, consumer engagement, and brand positioning, ultimately driving awareness and adoption of innovative treatments for unmet medical needs. By leveraging customer insights and analytics, they create tailored marketing strategies that resonate with healthcare professionals and patients alike.

Marketing Management Team

The Regulatory Affairs Team at Idorsia plays a critical role in ensuring that the company’s biopharmaceutical products comply with global regulatory standards throughout their development lifecycle. This team collaborates closely with clinical and quality systems to navigate the complex landscape of drug approvals, advocate for patients’ needs, and support the launch of innovative therapies targeting significant medical needs across various disease areas.

Idorsia

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations Team

Drug Discovery Team

Quality Assurance and Compliance Team

Marketing Management Team

Regulatory Affairs Team

Offices

Idorsia

Org chart

Board & advisors

Teams

Leadership Team

Clinical Operations Team

Drug Discovery Team

Quality Assurance and Compliance Team

Marketing Management Team

Regulatory Affairs Team

Offices

Related companies